| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
54,225 |
44,757 |
$1.99M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,874 |
6,857 |
$339K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
8,450 |
6,826 |
$82K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,554 |
2,962 |
$63K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,887 |
3,595 |
$57K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
11,773 |
10,060 |
$48K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
594 |
566 |
$42K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
457 |
434 |
$29K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,607 |
1,463 |
$12K |
| 81025 |
|
2,663 |
2,285 |
$10K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
126 |
124 |
$8K |
| 36415 |
Collection of venous blood by venipuncture |
9,735 |
8,375 |
$8K |
| 81003 |
|
5,685 |
4,942 |
$7K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
1,087 |
936 |
$5K |
| 99173 |
|
1,550 |
1,461 |
$5K |
| 36416 |
|
7,183 |
6,146 |
$5K |
| 3074F |
|
12,957 |
11,142 |
$5K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,052 |
903 |
$5K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
361 |
311 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
159 |
153 |
$4K |
| 1160F |
|
15,030 |
11,691 |
$4K |
| 1159F |
|
15,031 |
11,685 |
$4K |
| 3078F |
|
10,536 |
9,110 |
$4K |
| 3008F |
|
13,628 |
10,647 |
$4K |
| 90688 |
|
269 |
219 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
43 |
40 |
$3K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
44 |
38 |
$3K |
| 3079F |
|
6,348 |
5,430 |
$3K |
| 87210 |
|
977 |
815 |
$2K |
| 85013 |
|
553 |
519 |
$2K |
| 3075F |
|
3,561 |
3,080 |
$2K |
| 92551 |
|
262 |
251 |
$2K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
75 |
69 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,063 |
905 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
176 |
143 |
$1K |
| J0945 |
Injection, brompheniramine maleate, per 10 mg |
498 |
435 |
$939.06 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
506 |
445 |
$713.71 |
| 3080F |
|
717 |
614 |
$693.33 |
| 3077F |
|
1,539 |
1,259 |
$676.82 |
| 71046 |
Radiologic examination, chest; 2 views |
45 |
30 |
$393.45 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,023 |
877 |
$376.30 |
| 93000 |
|
38 |
28 |
$305.12 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
111 |
93 |
$215.28 |
| 90656 |
|
13 |
13 |
$211.46 |
| 82948 |
|
141 |
110 |
$204.26 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
17 |
16 |
$193.58 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
12 |
12 |
$61.19 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
332 |
233 |
$0.00 |
| 90662 |
|
19 |
14 |
$0.00 |
| 1158F |
|
19 |
14 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
104 |
85 |
$0.00 |
| 3044F |
|
16 |
12 |
$0.00 |
| 1170F |
|
19 |
14 |
$0.00 |